Microdosing semaglutide, typically at doses of 0.1 to 0.5 mg per week, has gained attention for researchers who want milder appetite effects, metabolic benefits without dramatic weight loss, or a more conservative approach
Improved Blood Sugar Control Semaglutide and Tirzepatide can also lead to better blood sugar control, making them beneficial for individuals with type 2 diabetes or prediabetes
In both conditions, one would hypothesized that the glucose-dependency of GLP-1 is also lost given the lack of functional K ATP channels in the first, and the concomitant hyperglycemia in the second
Nonetheless, given the non-randomized design, residual confounding cannot be entirely excluded
Omega-3 fatty acids reduce the inflammation that can accompany rapid weight loss
200